YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver InjuryLara Planas‐Paz, Jan S. Tchorz, Jasna Jetzer et al.|Cell stem cell|2019Cited by 212
Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative ColitisShannon Telesco, Linda E. Greenbaum, Carrie Brodmerkel et al.|Gastroenterology|2018Cited by 73
NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivoKenji Namoto, Michael T. Dill, Clara Baader et al.|Cell stem cell|2024Cited by 36
Prediction of Non-Response to Anti-Tnf Therapy in Ulcerative Colitis: Implications for Patient Stratification for IBD Trials and Novel Treatment ParadigmsShannon Telesco, Carrie Brodmerkel, Linda E. Greenbaum et al.|Gastroenterology|2017Cited by 1